Take Homes in Leukemia

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.

Healio spoke with John Molina, MD, MEd, about research on the use of minimal residual disease testing in acute lymphoblastic leukemia presented at Society of Hematologic Oncology Annual Meeting.

In this interview, Naval Daver, MD, discusses a session on myelodysplastic syndrome from Society of Hematologic Oncology Annual Meeting.

Naval Daver, MD, spoke with Healio about updates in FLT3-mutated acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Healio spoke with Naval Daver, MD, about a debate on the best duration of venetoclax in combination with azacitidine among older patients with acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

Healio spoke with Naval Daver, MD, about presentations on the use of molecular therapies, including menin inhibitors, in the treatment of acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

SAN DIEGO — Akriti Jain, MD, highlights presentations from ASH Annual Meeting and Exposition focused on triplet combination therapy for patients with acute myeloid leukemia.

SAN DIEGO — Akriti Jain, MD, spoke with Healio about combination therapy with venetoclax for acute myeloid leukemia presented at ASH Annual Meeting and Exposition.

SAN DIEGO — In this video, Akriti Jain, MD, discusses a new targeted monotherapy being used for patients with acute myeloid leukemia, tuspetinib.